IT’S UNCLEAR, BUT THE BENEFIT SEEMS MOSTLY TO COME FROM THE WEIGHT LOSS, WHICH ISN’T SURPRISING: Weight-loss drug Wegovy may benefit patients with heart failure.
Caveats: It’s a relatively small study, and it’s funded by Wegovy’s maker.
IT’S UNCLEAR, BUT THE BENEFIT SEEMS MOSTLY TO COME FROM THE WEIGHT LOSS, WHICH ISN’T SURPRISING: Weight-loss drug Wegovy may benefit patients with heart failure.
Caveats: It’s a relatively small study, and it’s funded by Wegovy’s maker.
InstaPundit is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.